glp 1 and kidney disease GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal GLP1 Receptor Agonists vs SGLT2-I

Pharmacy-grade sourcing: both Tesamorelin and Ipamorelin are dispensed through a licensed compounding pharmacy

Glutathione is an antioxidant that may help to reduce oxidative stress in the skin

Figure 1b visualizes these data together with four activity regions representing the possible potency measurements at hGCG and hGLP-1 for dual-agonist peptides

I have 4 more treatments to go in this 12 treatment cycle

Safety considerations: GLP-1 receptor agonists are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Individual red and green channels of RBG images from the main figures are shown in Supplementary Fig